日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity

PD-1和CTLA-4阻断疗法反应和耐药性的新兴动态通路:直面复杂性以应对不确定性

Relecom, Allan; Merhi, Maysaloun; Inchakalody, Varghese; Uddin, Shahab; Rinchai, Darawan; Bedognetti, Davide; Dermime, Said

Screening Status as a Determinant of Choice of Colorectal Cancer Screening Method: A Population-Based Informed Survey

筛查状况作为结直肠癌筛查方法选择的决定因素:一项基于人群的知情调查

Sandoval, José Luis; Relecom, Allan; Ducros, Cyril; Bulliard, Jean-Luc; Arzel, Beatrice; Guessous, Idris

Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatment: a case report

一例接受联合放射免疫疗法治疗的转移性胃癌患者体内持续存在抗NY-ESO-1特异性T细胞并表达差异性生物标志物:病例报告

Merhi, Maysaloun; Raza, Afsheen; Inchakalody, Varghese Philipose; Siveen, Kodappully S; Kumar, Deepak; Sahir, Fairooz; Mestiri, Sarra; Hydrose, Shereena; Allahverdi, Niloofar; Jalis, Munir; Relecom, Allan; Al Zaidan, Lobna; Hamid, Mohamed Sir Elkhatim; Mostafa, Mai; Gul, Abdul Rehman Zar; Uddin, Shahab; Al Homsi, Mohammed; Dermime, Said

Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy

激活针对 NY-ESO-1 癌睾丸抗原的免疫反应,作为癌症免疫治疗的潜在靶点

Raza, Afsheen; Merhi, Maysaloun; Inchakalody, Varghese Philipose; Krishnankutty, Roopesh; Relecom, Allan; Uddin, Shahab; Dermime, Said